Cysteamine derivatives for oral treatment of seborrhea

Details Cysteamine derivatives for oral treatment of seborrhea Cysteamine derivatives for oral treatment of seborrhea

1977-04-22

1979-02-13

Meyers, Albert T.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424DIG4, 424316, 424319, 424321, 424324, 424325, 424330, A61K 3116, A61K 31165, A61K 3118

Patent

active

041396359

ABSTRACT:
A method for treating a scalp characterized by an excessive secretion of sebum, to improve the condition thereof by reducing said excessive secretion comprising orally administering to a human being having a scalp so characterized a therapeutic composition comprising an ingestible carrier admixed with, as a non-toxic active compound, cysteine or cysteamine derivatives, the active compound is present in amounts of about 0.75-3 weight percent of the composition which is administered at a rate of about 1-5 mg/kg/day based on the weight of the human being during a period of about 15 days.

REFERENCES:
patent: 2769839 (1956-11-01), Fincke
patent: 2835704 (1958-05-01), Walton

Affiliated with

Also associated with

Rating

Cysteamine derivatives for oral treatment of seborrhea does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cysteamine derivatives for oral treatment of seborrhea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cysteamine derivatives for oral treatment of seborrhea will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-691650